23andMe Lays Off 40 Percent of its Staff, Ends All Therapy Programs
As founder and CEO Anne Wojcicki struggles to take the company private, 200 jobs are cut as part of its restructuring plan.
23andMe cuts 40% of its workforce, discontinues all therapy programs
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
Meet Amperity’s new CEO: Former Salesforce exec takes reins at customer data startup
Tony Alika Owens, a longtime tech exec who previously spent a decade at Salesforce, was named CEO at Amperity, a ...
Hosted on MSN17h
23andMe to Cut 40% of Its Staff Amid Grim Financials
The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...
23andMe is laying off 40 percent of its staff
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
The Columbian14h
Vancouver-based Absci marks major milestone in partnership with AstraZeneca on artificial intelligence-generated antibody
On the heels of releasing its latest financial statement, Vancouver-based biotechnology company Absci announced it has met its first milestone in its collaboration with pharmaceutical giant AstraZenec ...
Business Insider12h
The full list of major US companies slashing staff this year, including Goldman Sachs, Meta, and 23andMe
23andMe is cutting 40% of its staff Genetic testing company 23andMe is cutting 200 employees, or 40% of its workforce, to reduce costs and refocus its business. The Bay Area-based company is also ...